Our mission is dedicated to improving the application and success of hematopoietic cell transplantation and related cellular therapies. We strive to be the leading organization promoting research, education and clinical practice in the field.
Become a Member
ASTCT Talks features industry leaders coming together to tackle important subjects in the growing field of transplantation and cellular therapy. You can listen to ASTCT Talks on the following platforms: Spotify, Google Podcasts and Apple Podcasts.
Listen Here
Now Available! Access the latest issue of Transplantation and Cellular Therapy
Read the Journal
Chimeric antigen receptor(CAR)-engineered natural killer (NK) cells designed with a CD28 costimulatory domain have superior anti-tumor efficacy and long-term cytotoxicity, research indicates.
View More
Check Out the Guideline
This webinar is intended for pharmacists and other members of the health care team who are involved in managing patients undergoing CAR T-cell therapy or hematopoietic stem cell transplant. The journal club consists of two, 30-minute journal club presentations, which include 20 minutes for the presentation and 10 minutes for discussion and a Q&A session
This third webinar of 2024 presented by the Palliative Care SIG will focus on lessons learned in the field and important research questions that must be answered in the future to further advance the science of palliative and supportive care to meet the needs of patients throughout the continuum of the illness.
Chronic GvHD remains a primary driver of transplant-related morbidity and mortality, particularly due to infection. Preventative strategies including antimicrobial therapy and vaccination are critical to enhance protection against life-threatening infection in patients experiencing chronic GvHD following allogeneic hematopoietic cell transplantation (HCT).
More Meetings
Browse all Education